These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17679790)

  • 41. Follicle-Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10-Year Risk of Cardiovascular Disease in Postmenopausal Women.
    Wang N; Shao H; Chen Y; Xia F; Chi C; Li Q; Han B; Teng Y; Lu Y
    J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular risk factors and recommended lipid goals attainment among patients referred in a tertiary care lipid clinic.
    Pirro M; Del Giorno R; Lupattelli G; Mannarino MR; Roscini AR; Covelli D; Schillaci G; Pasqualini L; Bagaglia F; Siepi D; Mannarino E
    Eur J Intern Med; 2011 Aug; 22(4):412-7. PubMed ID: 21767761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dyslipidaemia, hypercoagulability and the metabolic syndrome.
    Kakafika AI; Liberopoulos EN; Karagiannis A; Athyros VG; Mikhailidis DP
    Curr Vasc Pharmacol; 2006 Jul; 4(3):175-83. PubMed ID: 16842135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden.
    Welin L; Adlerberth A; Caidahl K; Eriksson H; Hansson PO; Johansson S; Rosengren A; Svärdsudd K; Welin C; Wilhelmsen L
    BMC Public Health; 2008 Dec; 8():403. PubMed ID: 19063738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of Metabolic Syndrome and its Related Risk Factors in the City of Oran, Algeria: the ISOR Study.
    Houti L; Hamani-Medjaoui I; Lardjam-Hetraf SA; Ouhaibi-Djellouli H; Chougrani S; Goumidi L; Mediene-Benchekor S
    Ethn Dis; 2016 Jan; 26(1):99-106. PubMed ID: 26843802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014.
    Sun X; Du T
    BMC Public Health; 2017 Nov; 17(1):893. PubMed ID: 29166886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrates for treatment of the metabolic syndrome.
    Maki KC
    Curr Atheroscler Rep; 2004 Jan; 6(1):45-51. PubMed ID: 14662107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.
    Alexander CM; Landsman PB; Teutsch SM; Haffner SM; ;
    Diabetes; 2003 May; 52(5):1210-4. PubMed ID: 12716754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of metabolic syndrome according to different definitions in a hypertensive population.
    Lioudaki E; Vrentzos GE; Mavrogeni H; Zeniodi MH; Ganotakis ES; Mikhailidis DP; Papadakis JA
    Angiology; 2012 Jan; 63(1):39-47. PubMed ID: 21555311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex-specific clustering of metabolic risk factors and their association with incident cardiovascular diseases: A population-based prospective study.
    Ramezankhani A; Azizi F; Hadaegh F; Eskandari F
    Atherosclerosis; 2017 Aug; 263():249-256. PubMed ID: 28683364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic syndrome: cardiovascular risk assessment and management.
    Wong ND
    Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.
    Glass TR; Ungsedhapand C; Wolbers M; Weber R; Vernazza PL; Rickenbach M; Furrer H; Bernasconi E; Cavassini M; Hirschel B; Battegay M; Bucher HC;
    HIV Med; 2006 Sep; 7(6):404-10. PubMed ID: 16903986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary.
    ; ; Grundy SM; Cleeman JI; Daniels SR; Donato KA; Eckel RH; Franklin BA; Gordon DJ; Krauss RM; Savage PJ; Smith SC; Spertus JA; Costa F
    Cardiol Rev; 2005; 13(6):322-7. PubMed ID: 16708441
    [No Abstract]   [Full Text] [Related]  

  • 59. Metabolic Syndrome in Endometrial Cancer Patients: Systematic Review.
    Adambekov S; Yi Y; Fabio A; Miljkovic I; Edwards RP; Lopa S; Linkov F
    Metab Syndr Relat Disord; 2019 Jun; 17(5):241-249. PubMed ID: 30932741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of definitions of metabolic syndrome in relation to the risk of developing stroke and coronary heart disease in Finnish and Swedish cohorts.
    Qiao Q; Laatikainen T; Zethelius B; Stegmayr B; Eliasson M; Jousilahti P; Tuomilehto J
    Stroke; 2009 Feb; 40(2):337-43. PubMed ID: 19109550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.